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Background: We have previously shown that chloramphenicol, a potent inhibitor of certain cytochrome P450 monooxygenases, reduces infarct size 
when administered prior to or after ischemia. It has been also known that chloramphenicol induces autophagy and that autophagy plays a role in 
cardioprotection, but it has not been investigated whether autophagy is necessary for the cardioprotection afforded by chloramphenicol.
Methods: Here we perfused isolated rat hearts in Langendorff mode with Krebs-Henseleit solution containing 300 μM chloramphenicol. After 
20 min aerobic perfusion hearts were subjected to a 30 min global ischemia and 2 h reperfusion. In order to inhibit autophagy, a group of hearts 
was treated with 200 nM recombinant Tat-Atg5K130R protein [to block autophagosomes formation] or 5 μM chloroquine [to block lysosomal 
acidification and degradation of autophagolysosome contents] for 15 min prior to the perfusion of chloramphenicol. Creatine kinase release was 
measured from the coronary effluent 15 min after ischemia and infarct size was assessed by TTC staining at the end of reperfusion.
Results: Chloramphenicol treatment significantly reduced infarct size and the release of creatine kinase from rat hearts. Blocking the formation of 
autophagosomes by a pretreatment with recombinant Tat-Atg5K130R protein abolished the cardioprotective effects of chloramphenicol; however, 
blocking the lysosomal degradation of autophagosomes by chloroquine did not alter the cardioprotective effects of chloramphenicol.
Conclusions: These results demonstrate that autophagy is required for the cardioprotection conferred by chloramphenicol. Furthermore, we can 
conclude that the engulfment of damaged organelles by autophagosomes and not the recycling of the degraded cellular material might be the key 
step in the cardioprotection afforded by autophagy-modulating agents.
